Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer

NCT06550453 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Colorectal Cancer

Interventions

DRUG: Pabolizumab+ bevacizumab and CapeOX (bevacizumab + oxaliplatin + capecitabine)

Sponsor

yangjianjun